Company news
Clinuvel Pharmaceuticals Limited news in 2018
Clinuvel Pharmaceuticals Limited's news releases, calls and decks from 2018, newest first.
CUV103 Singaporean Phase II vitiligo study results
December 18, 2018
Appeal Upheld Against NICE Recommendation in England
October 9, 2018
S&P DJI Announces September 2018 Quarterly Rebalance
September 6, 2018
US FDA Update
September 4, 2018
CLINUVEL completes SCENESSE FDA Filing
June 25, 2018
NICE maintains position not to recommend SCENESSE
May 22, 2018
CLINUVEL Regulatory Update
May 13, 2018
CLINUVEL to take 100% ownership of VALLAURIX joint venture
May 1, 2018
CLINUVEL hosts European EPP Expert Meeting
March 18, 2018
Decks in 2018
- Shareholder Meeting (November 2018)
Shareholder meeting · 39 slides · Nov 21, 2018
- Sachs 18th Annual Biotech in Europe Forum 2018
Conference · 13 slides · Oct 8, 2018
- Nasdaq Virtual Investor Conference 2018
Conference · 15 slides · Sep 20, 2018